Jens Rueter

Hematology

200 Somerset St
Millinocket, ME 04462

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

Journal: JCO global oncology

Published: August 13, 2026

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology

Published: April 22, 2026

Building a genomics-capable cancer workforce: a competency-based framework for education and training in precision oncology.

Building a genomics-capable cancer workforce: a competency-based framework for education and training in precision oncology.

Journal: EClinicalMedicine

Published: April 20, 2026

Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology

Published: January 15, 2026

Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology

Published: October 16, 2025

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Journal: Oncotarget

Published: March 12, 2025

Advancing Genomic Cancer Medicine in Rural and Underserved States.

Advancing Genomic Cancer Medicine in Rural and Underserved States.

Journal: JAMA oncology

Published: July 18, 2024

Socioeconomic and urban-rural disparities in genome-matched treatment receipt and survival after genomic tumor testing.

Socioeconomic and urban-rural disparities in genome-matched treatment receipt and survival after genomic tumor testing.

Journal: JNCI cancer spectrum

Published: May 09, 2024

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Journal: JCO precision oncology

Published: February 14, 2024

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI).

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI).

Journal: NPJ precision oncology

Published: June 11, 2023

The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State.

The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State.

Journal: JCO precision oncology

Published: May 10, 2023

Urban-Rural and Socioeconomic Differences in Patient Knowledge and Perceptions of Genomic Tumor Testing.

Urban-Rural and Socioeconomic Differences in Patient Knowledge and Perceptions of Genomic Tumor Testing.

Journal: JCO precision oncology

Published: March 09, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026